CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
07 January 2020 - 8:05AM
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company
focused on creating transformative gene-based medicines for serious
diseases, today announced that Samarth Kulkarni, Ph.D., Chief
Executive Officer of CRISPR Therapeutics, is scheduled to present
at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View
from the Top conference on Thursday, January 9, 2020, at 1:10 p.m.
ET.
A live webcast of the fireside chat will be available on the
"Events & Presentations" page in the Investors section of the
Company's website at https://crisprtx.com/events. A replay of the
webcast will be archived on the Company's website for 14 days
following the presentation.
About CRISPR TherapeuticsCRISPR
Therapeutics is a leading gene editing company focused on
developing transformative gene-based medicines for serious diseases
using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a
revolutionary gene editing technology that allows for precise,
directed changes to genomic DNA. CRISPR Therapeutics has
established a portfolio of therapeutic programs across a broad
range of disease areas including hemoglobinopathies, oncology,
regenerative medicine and rare diseases. To accelerate and expand
its efforts, CRISPR Therapeutics has established strategic
collaborations with leading companies including Bayer AG, Vertex
Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is
headquartered in Zug, Switzerland, with its wholly-owned U.S.
subsidiary, CRISPR Therapeutics, Inc., and R&D operations based
in Cambridge, Massachusetts, and business offices in London, United
Kingdom. For more information, please visit www.crisprtx.com.
Investor Contact:Susan
Kimsusan.kim@crisprtx.com
Media Contact:Jennifer PaganelliWCG on behalf
of CRISPR347-658-8290jpaganelli@wcgworld.com
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Apr 2024 to May 2024
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From May 2023 to May 2024